photonamic
markets Gliolan (Gleolan in the US), a 5-aminolevulinic acid (5-ALA) agent that patients take before glioma surgery so that tumor tissue fluoresces under blue light, letting neurosurgeons achieve more complete resections than white-light surgery alone.
- Country
- Germany
Commercial
Gliolan / Gleolan (5-ALA)
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Intraoperative molecular diagnostics | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.